Literature DB >> 6603249

Treatment of chancroid with erythromycin. A clinical and microbiological appraisal.

M O Duncan, Y R Bilgeri, H G Fehler, R C Ballard.   

Abstract

One hundred and thirty seven patients presenting with genital ulcerations from which Haemophilus ducreyi was isolated were treated with erythromycin stearate 500 mg every six hours for seven days. Of these, 91 (66%) had associated inguinal lymphadenopathy. Only two of the 100 patients who returned after one week showed no clinical improvement. Despite decrease in size H ducreyi was reisolated from the ulcers of three patients, two of whom had not complied with treatment. The patients were treated for a further week either with erythromycin or with a placebo preparation and on day 14 no discernible difference in clinical response was evident. H ducreyi was not reisolated from any lesion. In contrast, the natural course of development of associated lymphadenopathy was not modified by treatment. H ducreyi was not, however, isolated from any gland after the start of treatment. Side effects attributable to erythromycin were minimal and treatment had to be discontinued in only two patients. This study clearly indicates that treatment with erythromycin for one week results in rapid healing of lesions and the elimination of H ducreyi from both ulcers and associated lymph glands.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603249      PMCID: PMC1046197          DOI: 10.1136/sti.59.4.265

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


  8 in total

1.  A comparison of the in vitro activity of rosamicin, erythromycin, clindamycin, metroidazole and ornidazole against Haemophilus ducreyi, including beta-lactamase producing strains.

Authors:  S Feltham; A R Ronald; W L Albritton
Journal:  J Antimicrob Chemother       Date:  1979-11       Impact factor: 5.790

2.  Treatment of chancroid with erythromycin.

Authors:  J L Carpenter; A Back; D Gehle; T Oberhoffer
Journal:  Sex Transm Dis       Date:  1981 Jul-Sep       Impact factor: 2.830

3.  Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg.

Authors:  Y R Bilgeri; R C Ballard; M O Duncan; A C Mauff; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

4.  A taxonomic study of the genus Haemophilus, with the proposal of a new species.

Authors:  M Kilian
Journal:  J Gen Microbiol       Date:  1976-03

5.  Modification of the microimmunofluorescence test to provide a routine serodiagnostic test for chlamydial infection.

Authors:  J D Treharne; S Darougar; B R Jones
Journal:  J Clin Pathol       Date:  1977-06       Impact factor: 3.411

6.  Comparison of specimen collection and laboratory techniques for isolation of Haemophilus ducreyi.

Authors:  G W Hammond; C J Lian; J C Wilt; A R Ronald
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

7.  Genital ulcers in Kenya. Clinical and laboratory study.

Authors:  H Nsanze; M V Fast; L J D'Costa; P Tukei; J Curran; A Ronald
Journal:  Br J Vener Dis       Date:  1981-12

8.  Cultivation of Chlamydia trachomatis in cycloheximide-treated mccoy cells.

Authors:  K T Ripa; P A Mårdh
Journal:  J Clin Microbiol       Date:  1977-10       Impact factor: 5.948

  8 in total
  4 in total

Review 1.  Treatment of chancroid.

Authors:  Y Dangor; R C Ballard; S D Miller; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

2.  Treating chancroid: summary of studies in southern Africa.

Authors:  R C Ballard; M O Duncan; H G Fehler; Y Dangor; F L Exposto; A S Latif
Journal:  Genitourin Med       Date:  1989-01

3.  Antimicrobial susceptibility and characterization of outer membrane proteins of Haemophilus ducreyi isolated in Thailand.

Authors:  D N Taylor; P Echeverria; S Hanchalay; C Pitarangsi; L Slootmans; P Piot
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

4.  Evaluation of 500- and 1,000-mg doses of ciprofloxacin for the treatment of chancroid.

Authors:  L Bodhidatta; D N Taylor; A Chitwarakorn; K Kuvanont; P Echeverria
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.